//fpnotebook.com/
Exercising with Infection
Aka: Exercising with Infection
- Physiology: Immune reaction to Exercise
- Increased
- Granulocytes
- Monocytes
- Lymphocytes
- Natural Killer Cells increased
- Not affected
- B Lymphocytes
- Physiology: Fever effect on Exercise
- Decreased cardiovascular parameters
- Cardiac Output
- Systemic Vascular Resistance (SVR)
- Blood Pressure
- Increased cardiovascular parameters
- Oxygen Consumption
- Heart Rate
- Fevers overall effect on Exercise
- Increased Effort and Fatigue
- Decreased Exercise Capacity
- Higher risk of Dehydration and Injury
- Contraindications to participation when febrile (>100.4F)
- Myalgias
- Cough or other Upper Respiratory symptoms
- Specific Conditions
- Myocarditis
- Associated with URI (Coxsackie Virus)
- Return to play in 6 months
- Epstein-Barr Virus (Mononucleosis)
- Athletes have milder course of Mononucleosis
- Requires 3-6 months to return to prior fitness level
- Avoid Contact Sports for at least 4 weeks
- Incidence Splenic Rupture (days 4-21): 0.1-0.2%
- Return to play
- Three weeks: Moderate training indications
- No Splenomegaly
- No fever
- Liver Function Tests Normal
- Asymptomatic
- Four weeks: Strenuous activity allowed
- Infectious Diarrhea
- Prophylaxis not generally recommended
- Otitis Externa
- May return to water sports 2-3 days after treatment
- Tight ear plugs used for earlier return
- Human Immunodeficiency Virus (HIV Infection)
- Incidence of HIV in College Students: 1 in 500
- Athletes risk HIV Transmission <1 per million games
- NCAA, USOC, NFHSAA: unrestricted activity in HIV
- No routine HIV Screening in sports
- Prevention: Immunizations for athletes
- Tetanus Vaccine
- Influenza Vaccine
- Hepatitis B Vaccine
- MMR Vaccine